Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG)

CAPS Rating: 2 out of 5

The Company is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs.

Recs

0
Player Avatar pchop123 (79.53) Submitted: 11/12/2012 5:06:40 PM : Outperform Start Price: $4.31 ROSG Score: +9.46

no longer cash strapped & ready to move out

Featured Broker Partners


Advertisement